Dr. Altwegg is currently a first- year Translational Science Interagency Postdoctoral Fellow, a dual fellowship between NIH/NCATS and the FDA. She is committed to improving our understanding of the molecular mechanisms of cancers with a goal of developing high-throughput screening bioassays and discovering next-generation translational cancer therapeutics to positively enhance disease-free interval and survival outcomes. Her research is dedicated to uncovering the mechanistic contributions of oncogenes, epigenetics, diet-gene interactions, and signaling cascades spearheaded toward the discovery and development of novel translational advances in head and neck squamous cell carcinoma, pancreatic cancer, and women’s cancer therapeutics. (She also fosters rescue dogs!)